Uric acid formation is driven by crosstalk between skeletal muscle and other cell types
JCI Insight · 2024
DOI: 10.1172/jci.insight.171815 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCI Insight, 2024. Verfasst von Spencer G Miller und 5 weiteren Autor:innen. Beteiligte Einrichtung: Indiana Center for Musculoskeletal Health and. Hauptthemen laut MEDLINE: Uric Acid, Endothelial Cells. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAMS NIH HHS, NIDDK NIH HHS, National Institute of Arthritis and Musculoskeletal and Skin Diseases.
Abstract (Originalsprache)
Hyperuricemia is implicated in numerous pathologies, but the mechanisms underlying uric acid production are poorly understood. Using a combination of mouse studies, cell culture studies, and human serum samples, we sought to determine the cellular source of uric acid. In mice, fasting and glucocorticoid treatment increased serum uric acid and uric acid release from ex vivo–incubated skeletal muscle. In vitro, glucocorticoids and the transcription factor FoxO3 increased purine nucleotide degradation and purine release from differentiated muscle cells, which coincided with the transcriptional upregulation of AMP deaminase 3, a rate-limiting enzyme in adenine nucleotide degradation. Heavy isotope tracing during coculture experiments revealed that oxidation of muscle purines to uric acid required their transfer from muscle cells to a cell type that expresses xanthine oxidoreductase, such as endothelial cells. Last, in healthy women, matched for age and body composition, serum uric acid was greater in individuals scoring below average on standard physical function assessments. Together, these studies reveal skeletal muscle purine degradation is an underlying driver of uric acid production, with the final step of uric acid production occurring primarily in a nonmuscle cell type. This suggests that skeletal muscle fiber purine degradation may represent a therapeutic target to reduce serum uric acid and treat numerous pathologies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Indiana Center for Musculoskeletal Health and.
- Department of Anatomy, Cell Biology & Physiology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
- Department of Kinesiology, East Carolina University, Greenville, North Carolina, USA.
Förderung
- NIAMS NIH HHS
- NIDDK NIH HHS
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
- National Institute of Diabetes and Digestive and Kidney Diseases
- American Physiological Society
Zitieren
APA
Miller, S. G., Matias, C., Hafen, P. S., Law, A. S., Witczak, C. A., & Brault, J. J. (2024). Uric acid formation is driven by crosstalk between skeletal muscle and other cell types. JCI Insight. https://doi.org/10.1172/jci.insight.171815
Vancouver
Miller SG, Matias C, Hafen PS, Law AS, Witczak CA, Brault JJ. Uric acid formation is driven by crosstalk between skeletal muscle and other cell types. JCI Insight. 2024. doi:10.1172/jci.insight.171815
BibTeX
@article{Miller2024,
author = {Miller, Spencer G and Matias, Catalina and Hafen, Paul S and Law, Andrew S and Witczak, Carol A and Brault, Jeffrey J},
title = {Uric acid formation is driven by crosstalk between skeletal muscle and other cell types},
journal = {JCI Insight},
year = {2024},
doi = {10.1172/jci.insight.171815}
}
EUVIMED